Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones
Authors
Keywords
-
Journal
ANNALS OF MEDICINE
Volume 46, Issue 7, Pages 512-529
Publisher
Informa UK Limited
Online
2014-07-24
DOI
10.3109/07853890.2014.935470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains
- (2014) Jørgen Skov Jensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Study of Macrophage Functions in Murine J774 Cells and Human Activated THP-1 Cells Exposed to Oritavancin, a Lipoglycopeptide with High Cellular Accumulation
- (2014) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Activity against Staphylococcus aureus Causing Invasive Infections in U.S. and European Hospitals: a 5-Year International Surveillance Program
- (2014) R. E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic profiling of modithromycin: Assessment in a pneumococcal murine pneumonia model
- (2014) Dana Maglio et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In VitroActivity of Nemonoxacin, a Novel Nonfluorinated Quinolone Antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae
- (2013) Kobkul Chotikanatis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
- (2013) David Oldach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Nemonoxacin against Streptococcus pneumoniae in anIn VitroInfection Model
- (2013) Wang Liang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Activity against Naive and Induced Streptococcus pneumoniae Biofilms in anIn VitroPharmacodynamic Model
- (2013) Nathalie M. Vandevelde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Combined Pharmacodynamic Quantitative and Qualitative Model Reveals the Potent Activity of Daptomycin and Delafloxacin against Staphylococcus aureus Biofilms
- (2013) Julia Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011
- (2013) Birgitta Olsen et al. BMC INFECTIOUS DISEASES
- Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)
- (2013) Ronald N. Jones et al. Brazilian Journal of Infectious Diseases
- High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options
- (2013) M. J. Pond et al. CLINICAL INFECTIOUS DISEASES
- The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
- (2013) James S. Molton et al. CLINICAL INFECTIOUS DISEASES
- 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
- (2013) H. W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Comparison of pharmacokinetics between new quinolone antibiotics: the zabofloxacin hydrochloride capsule and the zabofloxacin aspartate tablet
- (2013) HyeKyung Han et al. CURRENT MEDICAL RESEARCH AND OPINION
- Resistance surveillance program report for selected European nations (2011)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Prevalence of antibiotic resistance in US hospitals
- (2013) John Edelsberg et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Prospects for new antibiotics: a molecule-centered perspective
- (2013) Christopher T Walsh et al. JOURNAL OF ANTIBIOTICS
- A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia
- (2013) P. S. Covington et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Report of the 13th Vancomycin-Resistant Staphylococcus aureus Isolate from the United States
- (2013) B. M. Limbago et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Geographic and Temporal Trends in Antimicrobial Nonsusceptibility in Streptococcus pneumoniae in the Post-vaccine era in the United States
- (2013) Ruth Link-Gelles et al. JOURNAL OF INFECTIOUS DISEASES
- New antibiotic agents in the pipeline and how they can help overcome microbial resistance
- (2013) Ian M. Gould et al. Virulence
- Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority Studies
- (2012) Marci L. English et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study
- (2012) So Hyun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of a Simulated Single 1,200-Milligram Dose of Oritavancin in anIn VitroPharmacokinetic/Pharmacodynamic Model of Methicillin-Resistant Staphylococcus aureus Infection
- (2012) Adam Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?
- (2012) Daniel Golparian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Evaluation of the Activity of Antibiotics against Hemin- and Menadione-Dependent Small-Colony Variants of Staphylococcus aureus in Models of Extracellular (Broth) and Intracellular (THP-1 Monocytes) Infections
- (2012) L. G. Garcia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects
- (2012) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan
- (2012) Chun-Hsing Liao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2
- (2012) G Eichenbaum et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oritavancin: A New Opportunity for Outpatient Therapy of Serious Infections
- (2012) A. Tice CLINICAL INFECTIOUS DISEASES
- Macrophage Killing of Bacterial and Fungal Pathogens Is Not Inhibited by Intense Intracellular Accumulation of the Lipoglycopeptide Antibiotic Oritavancin
- (2012) Beverlie Baquir et al. CLINICAL INFECTIOUS DISEASES
- In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans
- (2012) P. G. Ambrose et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
- (2012) CLINICAL INFECTIOUS DISEASES
- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains
- (2012) Douglas J. Biedenbach et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
- (2012) A. Dalhoff INFECTION
- Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia
- (2012) Douglas J. Biedenbach et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10
- (2012) L. Van Heirstraeten et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and -haemolytic streptococci collected from western European countries in 2011
- (2012) I. Morrissey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
- (2012) J. M. Remy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Summary of Pharmacokinetics and Tissue Distribution of a Broad-Spectrum Fluoroquinolone, JNJ-Q2
- (2012) J. M. Davenport et al. Clinical Pharmacology in Drug Development
- Human Pharmacokinetics and Safety Profile of Finafloxacin, a New Fluoroquinolone Antibiotic, in Healthy Volunteers
- (2011) Heena Patel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VitroActivities of the Novel Antibacterial Finafloxacin against Selected Gram-Positive and Gram-Negative Bacteria Tested in Mueller-Hinton Broth and Synthetic Urine
- (2011) Axel Dalhoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntibacterial Activity of Modithromycin, a Novel 6,11-Bridged Bicyclolide, against Respiratory Pathogens, Including Macrolide-Resistant Gram-Positive Cocci
- (2011) Takafumi Sato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- JNJ-Q2, a New Fluoroquinolone with PotentIn VitroActivity against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-Resistant Strains
- (2011) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
- (2011) J. Gordon Still et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Activity against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients, 2009-2010
- (2011) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial
- (2011) Lala M. Dunbar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSpectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
- (2011) Will Stubbings et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
- (2011) EMILIA TITELMAN et al. APMIS
- Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus
- (2011) Sofia Costa et al. BMC MICROBIOLOGY
- Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study
- (2011) George G. Zhanel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila
- (2011) Sandrine Lemaire et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae
- (2011) T. Sato et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efflux of novel quinolones in contemporary Streptococcus pneumoniae isolates from community-acquired pneumonia
- (2011) A. Lismond et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
- (2011) Peter G. Kelley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Overexpression ofpatAandpatB, Which Encode ABC Transporters, Is Associated with Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae
- (2010) Mark I. Garvey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
- (2010) D. Bertrand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
- (2010) D. J. J. van Rensburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone
- (2010) B. J. Morrow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of the Investigational Fluoroquinolone Finafloxacin against Ciprofloxacin-Sensitive and -Resistant Acinetobacter baumannii Isolates
- (2010) P. G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
- (2010) B. Llano-Sotelo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interactions of oritavancin, a new semi-synthetic lipoglycopeptide, with lipids extracted from Staphylococcus aureus
- (2010) Oscar Domenech et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae
- (2010) Hee Soo Park et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of oritavancin against community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA)
- (2010) Louis D. Saravolatz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance
- (2010) Nadine-C. Emrich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
- (2009) P. M. Roblin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101
- (2009) K. B. Waites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
- (2009) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers
- (2009) D. T. Chung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Nemonoxacin (TG-873870), a Novel Potent Broad-Spectrum Nonfluorinated Quinolone, in Healthy Volunteers
- (2009) L. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates
- (2009) H. J. Adam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains
- (2009) H. A. Nguyen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
- (2009) M.-L. Foucault et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
- (2009) F. F. Arhin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms
- (2009) P. McGhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin
- (2009) Françoise Van Bambeke et al. DRUG SAFETY
- Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales
- (2009) S. A. Chisholm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
- (2009) F. F. Arhin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan
- (2009) Y.-H. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains
- (2008) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections
- (2008) Françoise Van Bambeke et al. EXPERT OPINION ON PHARMACOTHERAPY
- Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin
- (2008) V. A. Luna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now